<DOC>
	<DOCNO>NCT01291017</DOCNO>
	<brief_summary>The purpose study determine efficacy toxicity study drug PD0332991 treatment patient Stage IV non-small cell lung cancer wildtype retinoblastoma protein ( RB ) inactivate cyclin dependent kinase ( CDK ) N2A tumor .</brief_summary>
	<brief_title>Cyclin Dependent Kinase ( CDK ) 4/6 Inhibitor , PD0332991 Advanced Non-small Cell Lung Cancer NSCLC .</brief_title>
	<detailed_description>The oral drug PD0332991 highly selective reversible inhibitor cyclin-dependent kinase 4 &amp; 6 study use treatment advance non-small cell lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Histologically cytologically proven non small cell lung cancer Stage IV ( M1a M1b ) disease . Patients may also recurrence earlystage disease locally advanced disease presence new distant metastasis . Cyclin dependent kinase ( CDK ) N2a ( p16 ) protein absent express low level tumor biopsy specimen Failed intolerant least one prior systemic chemotherapy regimen ( maximum number prior chemotherapy regimen ) Eastern cooperative oncology group ( ECOG ) performance status 02 Age &gt; 18 year . Adequate organ bone marrow function Measurable disease standard RECIST v1.1 criterion Life expectancy great 3 month Inability understand sign inform consent document Inability unwillingness take oral medication No available tissue specimen p16 analysis Chemotherapy radiotherapy within 3 week prior begin study drug Other investigational agent within 4 week prior begin study drug All side effect previous chemotherapy , radiotherapy investigational agent resolve , return baseline return Grade 1 toxicity ( exception grade 2 alopecia grade 2 peripheral neuropathy ) Major surgery within 4 week prior begin study drug Surgical scar previous surgery heal prior begin study drug Highdose chronic steroid use Highdose statin within 7 day History rhabdomyolysis Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , uncontrolled diabetes , stroke myocardial infarction within 3 month , psychiatric illness/social situation would limit compliance study requirement . Baseline correct QT interval ( QTc ) &gt; 470ms Preexisting clinically significant cardiac , hepatic renal dysfunction discretion treat physician Untreated uncontrolled ( symptomatic asymptomatic ) brain metastasis Leptomeningeal carcinomatosis Inability unwillingness use contraception treatment period patient reproductive potential . Pregnant breastfeed woman HIVpositive patient combination antiretroviral therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Advanced stage</keyword>
</DOC>